Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Fund of hedge funds group FRM comments on risk averse Fed

Tuesday, October 08, 2013

Beverly Chandler, Opalesque London:

FRM, Man Group’s $16.7bn fund of hedge funds business, has published its Early Bird notes on September admitting that, in contrast to their prediction, the Federal Reserve continued with monetary stimulus. "We are now confronted by a Fed that is likely to be more risk averse and for longer than we previously thought. It is more than possible that the price for the short term status quo is a more disorderly exit in the future; but for now there are more pressing concerns" the firm writes.

September saw large inflows into fixed rate products, the fourth largest weekly flow on record with $3.1bn, with significant cash still to be invested. FRM believes that emerging market assets were perhaps the clearest beneficiaries of the non-taper. "Though the fundamental problems with the balance of payments in several large emerging market countries remains, the short term pressure has at least somewhat abated. It was notable that following the meeting, currencies of those countries that have been most impacted by outflows were stronger against the USD, a reversal of the moves seen since the 'taper talk’ began. Across the board emerging market equities were stronger over the month, helped not only by the continuing liquidity, but also by a constructive set of data releases from China."

Despite all the good news, and relatively heavy volumes, FRM notes that the US market is no high......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner